Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Osteosarcoma 29Dendritic Cell Sarcoma, Interdigitating 25Lymphoma 20Burkitt Lymphoma 20Lymphoma, Large B-Cell, Diffuse 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Non-Hodgkin 16Leukemia 16Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Follicular 14Sarcoma 13Recurrence 13Multiple Myeloma 13Leukemia, Myeloid, Acute 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 12Lymphoma, B-Cell, Marginal Zone 12Hodgkin Disease 12Neoplasms, Plasma Cell 11Myelodysplastic Syndromes 11Leukemia, Myeloid, Accelerated Phase 11Myeloproliferative Disorders 10Leukemia, Myelomonocytic, Chronic 10Congenital Abnormalities 10Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic-Phase 9Blast Crisis 9Sezary Syndrome 8Primary Myelofibrosis 8Mycosis Fungoides 8

Interventions

Ibandronic Acid 8Gemcitabine 8Doxorubicin 6Cyclophosphamide 6Zoledronic Acid 5Radiation 4Nivolumab 4Irinotecan 4pembrolizumab 3Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Docetaxel 3Denosumab 3Cisplatin 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3regorafenib 2pegfilgrastim 2Tranexamic Acid 2Trabectedin 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiosurgery 2Quality of Life 2Proton Therapy 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Neoplasms × Methotrexate × Sarcoma × Clear all
NCT03277924 2024-08-13

ImmunoSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Completed
197 enrolled
Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Blokhin's Russian Cancer Research Center

Phase 2/3 Unknown
50 enrolled
Sarcoma

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡